Try our beta test site
2 studies found for:    18354418 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Melanoma Treatment With White Blood Cells That Destroy MART Expressing Tumor Cells
Conditions: Metastatic Melanoma;   Skin Cancer
Interventions: Drug: Fludarabine;   Drug: Cyclophosphamide;   Drug: Aldesleukin;   Drug: MART-1 Reactive CD8+ PBL
2 Recruiting Safety Study of Adoptive Transfer of Autologous IKDC-like Cells
Condition: Neoplasm Metastasis
Intervention: Other: autologous IKDC-like cells

Study has passed its completion date and status has not been verified in more than two years.